4 ms·
Research is expensive and quite risky, drug research especially. R&D investment by companies into more efficient manufacturing are definitely good things to le
by munk-a 8y ago
Research is expensive and quite risky, drug research especially. R&D investment by companies into more efficient manufacturing are definitely good things to let the free-market do as it will with - but drug innovation is currently highly subsidized by the government, and my hope is that it ends up being transitioned to being entirely subsidized. It's an academic pursuit so we want to encourage experimentation without personal financial risk - solving the problem by just remitting enough money to the pharma industry (in the form of unnegotiated prices leading to wild profits) is a highly inefficient allocation - there is no guarantee that a company will reinvest those profits into radical research (many times they won't instead preferring business concerns like a high dividend yield or stock buy backs to cement contained wealth) and, since the government is already subsidizing a lot of research, the "correct" move from a profit perspective is to avoid innovation costs and just focus on snapping up any new discoveries coming out of academia.
- refurb 8y agoNew discoveries coming out of academia are lucky if they are a decade and hundreds of millions of dollars away from being an actual drug. Usually what comes out of academia is an idea or starting point, not a drug. And no, drug innovation is not highly subsidized by the gov't. Just look at budgets. NIH budget is $38B, of which a fraction is actually spent on research leading to new drugs. PhRMA (just the largest drug companies) spent $71B in 2017.[1] And that ignores the billions spent by VCs to fund start-ups, another $13B in the first 10 months of 2017.[2] Adding it up, private spending on drug R&D is probably 5-10x that of what the gov't spends. [1]https://www.biopharmadive.com/news/phrma-research-development-spending-industry-report/529943/ https://www.biopharmadive.com/news/phrma-research-developmen... [2]http://www.pharmatimes.com/magazine/2018/december_2018/a_record-breaking_year_for_biotech_funding http://www.pharmatimes.com/magazine/2018/december_2018/a_rec...
- ptah 8y agopossibly privately funded research is not as cost effective as government funded